Citius Pharmaceuticals Inc. (NASDAQ:CTXR) went down by -2.65% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Biotechnology giant went up by $1.10 to trade ended Wednesday trading at $1.13. This is down from the $1.13 price recorded on Tuesday’s trading session. Its performance from the start of the year has also been positive, with CTXR up by 7.84% year-to-date.
Citius Pharmaceuticals Inc. (CTXR) started the day trading at $1.05 and recorded an intraday high of $1.11. It also recorded an intraday low of $1.01 during Wednesday’s trading session. Citius Pharmaceuticals Inc. is a very active stock that recorded a trading volume that is more than 12.34% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 3399478, which is more than 12.34 of the total average daily trading volume of 2.98 million.
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) 2020 Performance Impressive
The increase in CTXR’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of CTXR currently stands at $1.97, which is higher than the current trading price of the stock by 44.16%. However, CTXR’s current trading price is -175.0% lower than the 52-week low price of $0.40. In terms of trading volume, Citius Pharmaceuticals Inc. currently experienced healthy participation during the last trading session. 3399478 shares of Citius Pharmaceuticals Inc. were traded on the stock exchange on Wednesday, which is more than 12.34% of the 2.98 million average trading volume of the stock.
The performance of the stock has been positive over the past year. CTXR’s performance over the past one year has seen it surge by 12.24%, while the stock has gone up by 7.84% in the last six months. The quarterly performance of CTXR currently stands at 34.15%, and it is up by 21.94% in the last month. The only positive figure was from the weekly performance, which currently reads 26.44%. At the time of writing CTXR’s report, the company has a total market cap of $38.90M, making it one of the largest publicly-traded companies in the world.Citius Pharmaceuticals Inc. also has over 1 employees all over the world.
CTXR Insider Activities
For Citius Pharmaceuticals Inc., insiders hold 12.00% of all company shares. The insider transactions over the past six months are down by 0.00%. During that period, insiders bought 0 shares in 0 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Citius Pharmaceuticals Inc. now hold 14.9M shares, which is over 12.53% of the total company stocks. Institutional investors currently hold a large chunk of the CTXR shares, as they control 39.08% of the company’s total stock.
CTXR Fundamental Analysis
For Citius Pharmaceuticals Inc., the stock’s diluted earnings per share (EPS) stands at -0.64. In the coming year, analysts expect the EPS to be 0.74. The stock’s EPS growth this year is 33.90%, -6.20% in the previous five years. In terms of revenue, Citius Pharmaceuticals Inc.’s quarterly sales (YOY) is shrinking at -0.11, which is higher than the average annual revenue of -6.20% over the past half a decade.
CTXR Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of CTXR currently stands at 12.36%, while the SMA50 is 19.50%. The biggest one is the SMA200, which is currently reading 42.49% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 55.12.
